As of 2026-10-17, the Relative Valuation of Translate Bio Inc (TBIO) is (7,338.73) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 USD, the upside of Translate Bio Inc based on Relative Valuation is -19012342.8%.
The range of the Relative Valuation is (6,693.75) - (6,856.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.8x - 41.2x | 35.0x |
| Forward P/E multiples | 26.8x - 29.5x | 28.2x |
| Fair Price | (6,693.75) - (6,856.45) | (7,338.73) |
| Upside | -17341433.1% - -17762923.9% | -19012342.8% |
| Date | P/E |
| 2026-10-14 | -0.00 |
| 2026-10-13 | -0.00 |
| 2026-10-07 | -0.00 |
| 2026-10-02 | -0.00 |
| 2026-09-30 | -0.00 |
| 2026-09-29 | -0.00 |
| 2026-09-28 | -0.00 |
| 2026-09-25 | -0.00 |
| 2026-09-23 | -0.00 |
| 2026-09-17 | -0.00 |
| 2026-09-10 | -0.00 |
| 2026-08-28 | -0.00 |
| 2026-08-26 | -0.00 |
| 2026-08-19 | -0.00 |
| 2026-08-14 | -0.00 |
| 2026-07-23 | -0.00 |
| 2026-07-20 | -0.00 |